Since 2004, at least 50 deaths have been reported in women taking Yaz or Yasmin. Some of these women were as young as 17. In December of last year, two Food and Drug Administration (FDA) advisory committees recommended that the drugs carry stronger warnings about the risks of potentially life-threatening blood clots.
A key ingredient in these drugs can raise blood potassium levels and cause:
· Deep Vein Thrombosis (DVT)
· Pulmonary Embolism
· Venous Thromboembolism (VTE)
Please contact us today if you have suffered injuries after taking Yaz and for the latest Yaz lawsuit settlement news.
The FDA warns that use of the diabetes medication Actos® (pioglitazone) for more than one year has been associated with a 40% increase in risk for bladder cancer.